Rchr
J-GLOBAL ID:201801002171353204   Update date: Sep. 20, 2024

Ikeda Yoshiki

イケダ ヨシキ | Ikeda Yoshiki
Affiliation and department:
Job title: Assistant Professor
Research field  (1): Pharmaceuticals - chemistry and drug development
Research theme for competitive and other funds  (18):
  • 2023 - 2027 Development of innovative antibody technology for therapeutics of glioblastoma
  • 2024 - 2026 不妊症治療を目指した細胞接着活性化剤の開発
  • 2022 - 2026 中枢神経系の可塑的変化を病態基盤とする慢性疼痛とうつ病の新規分子機序の解明
  • 2021 - 2026 Development of next-generation-antibodies based on shark VNAR platform
  • 2024 - 2025 インテグリン阻害による新規神経膠芽腫治療薬の探索
Show all
Papers (24):
  • Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, Rigel Suzuki, Atsushi Hoshino, Akira Noguchi, Shunsuke Kita, Yuki Anraku, Emiko Igarashi, Yumiko Saga, et al. Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1. Structure. 2024
  • Yoshiki Ikeda, Mindy I Davis, Kazutaka Sumita, Yuxiang Zheng, Satoshi Kofuji, Mika Sasaki, Yoshihisa Hirota, Rajan Pragani, Min Shen, Matthew B Boxer, et al. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and biophysical research communications. 2023. 679. 116-121
  • Yoshihiro Ueda, Koichiro Higasa, Yuji Kamioka, Naoyuki Kondo, Shunsuke Horitani, Yoshiki Ikeda, Wolfgang Bergmeier, Yoshinori Fukui, Tatsuo Kinashi. Rap1 organizes lymphocyte front-back polarity via RhoA signaling and talin1. iScience. 2023. 26. 8. 107292-107292
  • Hiroko Ueda, Quynh Thuy Huong Tran, Linh Nguyen Truc Tran, Koichiro Higasa, Yoshiki Ikeda, Naoyuki Kondo, Masaki Hashiyada, Chika Sato, Yoshinori Sato, Akira Ashida, et al. Characterization of cytoskeletal and structural effects of INF2 variants causing glomerulopathy and neuropathy. Scientific reports. 2023. 13. 1. 12003-12003
  • Yuji Kamioka, Yoshihiro Ueda, Naoyuki Kondo, Keizo Tokuhiro, Yoshiki Ikeda, Wolfgang Bergmeier, Tatsuo Kinashi. Distinct bidirectional regulation of LFA1 and α4β7 by Rap1 and integrin adaptors in T cells under shear flow. Cell Reports. 2023. 42. 6. 112580-112580
more...
MISC (6):
more...
Patents (5):
  • Embryo implantation promoting drugs and its screening system
  • 窒素含有化合物、前記窒素含有化合物を含む組成物、及び腫瘍悪性度の予測マーカー
  • 抗SARS-CoV-2抗体
  • Therapeutic drug for myasthenia gravis
  • Nitrogen-containing compounds, and markers for predicting tumor malignancy
Books (2):
  • 実験医学増刊 Vol.35 No.10 がん代謝 ワールブルグを超えて全容解明に挑む
    羊土社 2017
  • 大腸菌におけるRNase EとRNA結合タンパク質Hfq間の相互作用領域の解析
    名古屋大学 2011
Lectures and oral presentations  (28):
  • 弱い相互作用を定量・可視化する”Hakoniwa(箱庭)”テクノロジー
    (Seeds-Hub フォーラム 2024)
  • Feel Like Makin’ the Drug ~ Create Miniature Antibodies ~
    (2024 iCeMS retreat 2024)
  • In silico解析技術の提供によるLG研究の加速
    (第1回 L-グルコース研究会 2024)
  • In silico解析によるアカデミア創薬の加速
    (角川ドワンゴ学園研究部 研究発表会 2024)
  • 「大学」って何してんの?
    (須磨学園中学校・高等学校 キャリアパスセミナー 2024)
more...
Professional career (1):
  • 理学 (名古屋大学)
Awards (5):
  • 2024/08 - 第35回 高遠シンポジウム 第35回 高遠桜雲賞
  • 2024/03 - 加藤記念バイオサイエンス振興財団 第35回加藤記念研究助成
  • 2023/03 - Kansai Medical University 2023 Best Researcher Award
  • 2022/03 - Kansai Medical University Outstanding Researcher evaluates
  • 2008/04 - 名古屋大学 Outstanding Graduate Student Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page